PlainRecalls
FDA Drug Low Class III Terminated

Claravis (isotretinoin capsules USP), 10mg, packaged in carton containing 3 Blister Packs of 10 Capsules Each (30 Capsules total); Rx only, TEVA PHARMACEUTICALS USA, Sellersville, PA 18960. NDC 00555-1054-86

Reported: October 12, 2016 Initiated: August 5, 2016 #D-0005-2017

Product Description

Claravis (isotretinoin capsules USP), 10mg, packaged in carton containing 3 Blister Packs of 10 Capsules Each (30 Capsules total); Rx only, TEVA PHARMACEUTICALS USA, Sellersville, PA 18960. NDC 00555-1054-86

Reason for Recall

Failed Impurities/Degradation Specifications.

Details

Recalling Firm
Teva North America
Units Affected
3,569 capsules
Distribution
Nationwide
Location
Horsham, PA

Frequently Asked Questions

What product was recalled?
Claravis (isotretinoin capsules USP), 10mg, packaged in carton containing 3 Blister Packs of 10 Capsules Each (30 Capsules total); Rx only, TEVA PHARMACEUTICALS USA, Sellersville, PA 18960. NDC 00555-1054-86. Recalled by Teva North America. Units affected: 3,569 capsules.
Why was this product recalled?
Failed Impurities/Degradation Specifications.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 12, 2016. Severity: Low. Recall number: D-0005-2017.